Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever

Table 3

HTL epitopes are presented with corresponding binding affinity and physiochemical properties.

Proteins	Start-end	Peptide	Percentile rank	Antigenicity	IFN epitope	Allergenicity	Solubility	Toxicity
Envelope glycoprotein	425-439	AQHLVYFRRKRSILW	1.3	1.06	+	0.23	1.04	-1.03
VP30	178-192	NRELLLLMARKMLPN	1.8	0.47	+	0.22	1.77	-1.22
	123-137	TLENLGHILSYLHRS	2.1	0.47	+	0.3	1.34	-1.27
VP24	150-164	SEWLLLEVTSAIHIS	0.6	0.93	+	0.27	0.86	-1.68

Antigenicity , IFN-gamma-inducing capability, nonallergenic threshold , solubility , and nontoxicity score of <0.